Fellow Dave Vereide is into bodybuilding. Literally. He and the Vereide Group grow precursors of human arterial cells, build colonies of dendritic cells (cells which can alert the rest of the immune system to the presence of a tumor), and use chick embryos to study the formation of early tissue layers for a possible future in which complex tissues, or even organs, can be grown to replace diseased, wounded, or malfunctioning ones. His work led to the development of a novel method for propagating precursors of human arterial cells that could potentially be used for drug discovery and gives the Vereide Group the ability to model key events during cardiovascular disease. Their persistent work to establish successful propagation techniques for dendritic cells also holds great promise for the advancement of a powerful immunotherapy (wherein a patient’s own immune system is directed against cancer cells). All of this just goes to show that Dave and the Vereide Group are doing the heavy lifting required to lay the foundation of knowledge necessary for generation of complex tissues and organs, ultimately to be used in clinical applications.
Areas of Expertise
- Stem cell biology
Ph.D. Cancer Biology, 2009, University of Wisconsin-Madison
B.S. Biological Sciences, 2003, University of Alaska-Anchorage
2011-2013 NIH Ruth L. Kirschstein National Research Service Award 5T32HG002760 Genomic Sciences Training Program
2007-2009 National Cancer Center Predoctoral Fellowship
2004-2005 NIH Ruth L. Kirschstein National Research Service Award T32 CA009135-30
- Vereide D, Seto E, Chiu YF, Hayes M, Tagawa T, Grundhoff A, Hammerschmidt W, and Sugden B. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene, 33(10):1258-64. PMCID: PMC3690170. March 2014. Epub March 2013.
- Vereide D and Sugden B. Lymphomas differ in their dependence on Epstein-Barr virus. Blood, 117(6):1977-85. PMCID: PMC3056644. February 2011. Epub November 2010.
- Vereide D and Sugden B. Insights into the evolution of lymphomas induced by Epstein-Barr virus. Advances in Cancer Research, 108:1-19. 2010. Review.
- Vereide D and Sugden B. Proof for EBV’s sustaining role in Burkitt’s lymphomas. Seminars in Cancer Biology, 19(6):389-93. PMCID: PMC2789873. December 2009. Epub July 2009. Review.